arbekacin and cephalosporin c

arbekacin has been researched along with cephalosporin c in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's7 (63.64)18.2507
2000's3 (27.27)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, K; Suzuki, Y; Yokota, N1
Niijima, T1
Goi, H; Hara, T; Kazuno, Y; Matsuhashi, Y; Sugano, T; Tanaka, Y; Watanabe, T; Yamamoto, H; Yokota, T1
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, K; Suzuki, Y; Yokota, N1
Kanno, M; Kawabata, T; Sobu, K; Takase, Y; Watanabe, T; Yoshida, T1
Arakawa, K; Kono, K; Takeda, S; Tatara, I1
Deguchi, T; Ito, Y; Kanematsu, M; Kawada, Y; Komeda, H; Okano, M; Saitoh, A; Takahashi, Y; Tokuyama, H; Yamada, S1
Higurashi, Y; Nakahara, K; Okuzumi, K; Yoneyama, A1
Fukuhara, J; Homma, S; Kouda, M; Takeuchi, M; Tamura, K; Udagawa, I1
Araake, M; Hara, T; Miyata, A; Ogawa, H; Tani, M1
Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H1

Reviews

1 review(s) available for arbekacin and cephalosporin c

ArticleYear
[New antimicrobial agent series XL: arbekacin].
    The Japanese journal of antibiotics, 1991, Volume: 44, Issue:7

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Humans; In Vitro Techniques; Methicillin Resistance; Mice; Staphylococcal Infections; Staphylococcus aureus

1991

Other Studies

10 other study(ies) available for arbekacin and cephalosporin c

ArticleYear
[Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. IV. Combined effects of arbekacin with cefmetazole or flomoxef].
    The Japanese journal of antibiotics, 1992, Volume: 45, Issue:10

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cefmetazole; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Methicillin Resistance; Staphylococcus aureus

1992
[Antibacterial activities of arbekacin, a new aminoglycoside antibiotic, against methicillin-cephem-resistant Staphylococcus aureus].
    The Japanese journal of antibiotics, 1987, Volume: 40, Issue:2

    Topics: Abscess; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Dibekacin; Kanamycin; Male; Methicillin; Mice; Penicillin Resistance; Skin Diseases; Staphylococcus aureus

1987
[Antibiotic efficacies of combined uses of arbekacin and various antibiotics against methicillin-resistant Staphylococcus aureus].
    The Japanese journal of antibiotics, 1994, Volume: 47, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Therapy, Combination; Fosfomycin; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Staphylococcus aureus

1994
[Basic studies on combination effects of arbekacin and beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus].
    The Japanese journal of antibiotics, 1994, Volume: 47, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Cephalosporins; Cilastatin; Dibekacin; Drug Therapy, Combination; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus

1994
In vitro activities of arbekacin, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    The Japanese journal of antibiotics, 1994, Volume: 47, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Ceftizoxime; Cephalosporins; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus

1994
[A study of methicillin-resistant Staphylococcus aureus (MRSA) infection in urological field].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1993, Volume: 84, Issue:3

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Humans; Immunocompromised Host; Methicillin Resistance; Minocycline; Serotyping; Staphylococcus aureus; Urologic Diseases; Vancomycin

1993
[The in vitro antibacterial activity of cefozopran against clinically isolated bacteria].
    The Japanese journal of antibiotics, 1997, Volume: 50, Issue:12

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefozopran; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Vancomycin

1997
[Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:3

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Teicoplanin; Vancomycin

2000
[Combination effect of arbekacin and cefepime on mixed culture of MRSA and P. aeruginosa].
    The Japanese journal of antibiotics, 2001, Volume: 54, Issue:2

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cefepime; Cephalosporins; Dibekacin; Drug Synergism; Drug Therapy, Combination; Humans; Methicillin Resistance; Pseudomonas aeruginosa; Staphylococcus aureus; Teicoplanin; Time Factors; Vancomycin

2001
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
    The Japanese journal of antibiotics, 2006, Volume: 59, Issue:3

    Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin

2006